Fairmount Funds Management LLC reports owning 20.0% of Mentari Therapeutics Inc.
In a Schedule 13D filed Nov 12, 2026, Fairmount Funds Management LLC reported holding 10.6 million shares of Mentari Therapeutics Inc. (MTRI) as of Nov 6, 2026, 20.0% of the class. (SEC EDGAR, SCHEDULE 13D, Nov 12, 2026)
By the MarginsX Data Desk, automated. Published November 14, 2026. Data as of November 12, 2026.
What the filer says it intends
On the purpose of the transaction, the filing says: “99% of the Company in the aggregate, based upon the Company's aggregate outstanding shares as of November 6, 2026. The Reporting Persons' securities include 10,555,507 shares of Common Stock directly held by Fund II, and exclude (i) 4,013,000 shares of Common Stock issuable upon conversion of 4,013 shares of Series …” (SEC EDGAR, SCHEDULE 13D, Nov 12, 2026)